secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001104659-25-008100
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio transfers listing to Nasdaq Capital Market; granted 180-day extension to meet $1.00 bid price
--------------------------------------------------------------------------------

- Received Nasdaq deficiency notice on Aug 1, 2024 for bid price below $1.00 for 30 consecutive days.
- Nasdaq approved transfer to Capital Market effective Jan 30, 2025; stock continues trading under PASG.
- Granted additional 180-day compliance period until July 28, 2025 to regain $1.00 minimum bid price.
- Company will monitor and consider options including reverse stock split if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465925008100/0001104659-25-008100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465925008100/tm254971d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-008100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer